Bumrungrad Hospital PCL
Bumrungrad Hospital Public Company Limited is a Thailand-based healthcare enterprise operating a major international private hospital and medical diagnostic center. The company operates the flagship Bumrungrad International Hospital in Bangkok, providing multi-specialty tertiary healthcare, complex surgical procedures, diagnostic imaging, and preventive health screenings. Primary revenues stem from inpatient and outpatient medical fees, surgical charges, diagnostic testing, and pharmaceutical sales. Bumrungrad Hospital serves domestic private patients, regional medical travelers, expatriates, and international medical tourists from the Middle East, Asia-Pacific, and Western nations. The enterprise holds a premier position as one of Southeast Asia's largest private healthcare institutions and a global leader in international medical tourism. Bumrungrad Hospital Public Company Limited is headquartered in Bangkok, Thailand, and its common shares are listed on the Stock Exchange of Thailand.
18 of the funds FundTelligence covers report a position in Bumrungrad Hospital PCL.
- Sector
- Health Care
- Country
- Thailand
- Funds holding it
- 18
Funds holding Bumrungrad Hospital PCL
- Handelsbanken Asia SMB — Handelsbanken · 2.02 % (full portfolio disclosed, August 2026)
- JPM ASEAN Equity Fund — JPM · 1.61 % (full portfolio disclosed, June 2026)
- Nordea Emerging Markets Sustainable Enhanced — Nordea Funds · 0.2 % (full portfolio disclosed, September 2026)
- KLP AksjeFremvoksende Markeder Flerfaktor — KLP · 0.15 % (full portfolio disclosed, June 2026)
- Lannebo Emerging Markets — Lannebo · 0.04 % (full portfolio disclosed, June 2026)
- KLP AksjeFremvoksende Markeder Indeks — KLP · 0.04 % (full portfolio disclosed, June 2026)
- DNB Emerging Markets Index — DNB · 0.03 % (full portfolio disclosed, September 2026)
- Danske Invest Global Emerging Markets Index Restricted — Danske Invest · 0.03 % (full portfolio disclosed, July 2026)
Showing the 8 largest of 18 funds holding it.